Rigaku and Emerald Bio announce strategic alliance in protein crystallography

Rigaku, a supplier of X-ray instrumentation and automation equipment for structural biology, has acquired the crystallisation reagent and consumable business, including Wizard screens, from protein science company Emerald Bio. In addition, both companies have agreed to work together to develop new products and solutions in the growing field of protein science.

“The addition of these consumables and screening kits is another step in creating a single contact point for our instrumentation customers, improving the efficiency of their workflow,” stated Catherine Klein, president of Rigaku Americas Corporation’s Life Sciences Division. “Further, having Emerald Bio as a development partner and customer will help ensure that we are at the forefront of new product needs in protein science.”

Emerald Bio CEO Johan Pontin said having Rigaku as a development partner is “ideal”. The company’s president, George Abe, added, “While we focus on our growing consulting solutions business, we can rely on Rigaku to support our own internal workflow needs and we now have a partner to build integrated solutions, including software, for our mutual customers.”